Inventor
ADDINGTON OTIS C
US25 patents
⚠️ This page may combine multiple inventors who share the name “ADDINGTON OTIS C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHOENIX BIOTECHNOLOGY INC
23 patentsUS10729735B1Aug 4, 2020
Method and compostitions for treating coronavirus infection
PHOENIX BIOTECHNOLOGY INC26 citations94
US9358293B2Jun 7, 2016
Method of treating neurological conditions with oleandrin
PHOENIX BIOTECHNOLOGY INC25 citations94
US9877979B2Jan 30, 2018
Method of treating neurological conditions with oleandrin
PHOENIX BIOTECHNOLOGY INC13 citations92
US9494589B2Nov 15, 2016
Method of determining the probability of a therapeutic response in cancer chemotherapy with cardiac glycoside
PHOENIX BIOTECHNOLOGY INC15 citations92
US9220778B2Dec 29, 2015
Method of treating neurological conditions with oleandrin-containing extract
PHOENIX BIOTECHNOLOGY INC25 citations92
US10226497B2Mar 12, 2019
Composition for and method of treating neurological conditions
PHOENIX BIOTECHNOLOGY INC10 citations84
US11123387B2Sep 21, 2021
Method and compositions for treating viral infection
PHOENIX BIOTECHNOLOGY INC1 citations73
US11013776B2May 25, 2021
Method and compositions for treating viral infection
PHOENIX BIOTECHNOLOGY INC1 citations73
US11007239B2May 18, 2021
Method and compositions for treating viral infection
PHOENIX BIOTECHNOLOGY INC1 citations73
US10980852B2Apr 20, 2021
Method and compositions for treating viral infection
PHOENIX BIOTECHNOLOGY INC1 citations73
US10874704B2Dec 29, 2020
Method and compositions for treating viral infection
PHOENIX BIOTECHNOLOGY INC1 citations73
US10702567B2Jul 7, 2020
Method and compositions for treating viral infection
PHOENIX BIOTECHNOLOGY INC1 citations73
US10596186B2Mar 24, 2020
Method and compositions for treating viral infections
PHOENIX BIOTECHNOLOGY INC4 citations73
US10307450B2Jun 4, 2019
Method of treating neurological conditions with extract of Nerium species or Thevetia species
PHOENIX BIOTECHNOLOGY INC4 citations73
US9846156B2Dec 19, 2017
Method of treatment employing cardiac glycoside
PHOENIX BIOTECHNOLOGY INC3 citations72
US10722482B2Jul 28, 2020
Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
PHOENIX BIOTECHNOLOGY INC2 citations69
US11324789B2May 10, 2022
Method and compositions for treating equine encephalitis
PHOENIX BIOTECHNOLOGY INC0 citations62
US10960037B2Mar 30, 2021
Method of treating neurological conditions with extract of Nerium species or Thevetia species
PHOENIX BIOTECHNOLOGY INC0 citations62
US10383886B2Aug 20, 2019
Method of treating neurological conditions with oleandrin
PHOENIX BIOTECHNOLOGY INC1 citations62
US12097234B2Sep 24, 2024
Extract containing oleandrin and method of production thereof
PHOENIX BIOTECHNOLOGY INC0 citations60
US11806359B2Nov 7, 2023
Method and compositions for treating Coronavirus infection
PHOENIX BIOTECHNOLOGY INC0 citations60
US10973785B2Apr 13, 2021
Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
PHOENIX BIOTECHNOLOGY INC1 citations59
US11331291B2May 17, 2022
Method of and improved composition for treating triterpene-responsive conditions, diseases or disorders
PHOENIX BIOTECHNOLOGY INC0 citations49